AlloVir lays off 95% of staffers af­ter shut­ter­ing PhI­II an­tivi­ral cell ther­a­py tri­als 

Last year
People
R&D

Evotec CEO Wern­er Lan­thaler re­signs; Af­ter No­vo deal, ex-For­ma chief ush­ers in new era at Paci­ra

Last year
People
Peer Review

In­tel­lia Ther­a­peu­tics cuts 15% of work­force, ex­tends cash run­way in­to mid-2026

Last year
People
R&D

Ap­plied Ther­a­peu­tics on part­ner­ship hunt as it seeks path for­ward af­ter PhI­II di­a­bet­ic car­diomy­opa­thy fail

Last year
R&D

Al­lo­gene Ther­a­peu­tics plans re­struc­tur­ing as it swaps out PhII CAR-T tri­al plans to leapfrog ri­vals

Last year
R&D
Cell/Gene Tx

Feng Zhang's CRISPR start­up Aera shrinks head­count by a quar­ter

Last year
People
Startups

Up­dat­ed: Delfi Di­ag­nos­tics hires Il­lu­mi­na’s chief com­mer­cial of­fi­cer as next CEO

Last year
People
Diagnostics

UCB de­parts in­dus­try trade group BIO, fol­low­ing Pfiz­er's ex­it late last year

Last year
Pharma

Re­vance los­es at­tempt to dis­miss Botox trade se­crets law­suit

Last year
Pharma
Law

FDA lifts par­tial clin­i­cal hold on In­nate's can­cer drug af­ter pa­tient death linked to dis­ease pro­gres­sion

Last year
Pharma
FDA+

Blue­bird snags more out­comes-based cov­er­age for its $3M+ sick­le cell gene ther­a­py

Last year
Cell/Gene Tx

Lil­ly says its weight loss drugs Moun­jaro and Zep­bound should­n't be used for 'cos­met­ic' rea­sons

Last year
Pharma
Marketing

Klick Health nabs award-win­ning cre­ative di­rec­tor Tim Jones to lead team in Eu­rope

Last year
Pharma
Marketing

House Re­pub­li­cans call on FDA to hand over in­fo on in­ter­nal sci­en­tif­ic dis­agree­ments

Last year
Pharma
FDA+

Ther­mo Fish­er to shut­ter Petaluma man­u­fac­tur­ing fa­cil­i­ty, lay off 74 staffers by Feb­ru­ary

Last year
People
Manufacturing

Scoop: Re­silience re­ceives Form 483 due to mold at Cana­di­an site, more lay­offs an­tic­i­pat­ed

Last year
People
FDA+

Ther­mo Fish­er ex­tends Olink ten­der of­fer; Bio­gen and Gink­go com­plete col­lab; WuXi signs biotech part­ner for AD­Cs

Last year
Manufacturing

Ab­b­Vie taps Umo­ja for new in vi­vo CAR-T deal

Last year
Deals
Cell/Gene Tx

Wal­greens’ new CEO slash­es div­i­dend near­ly in half as stock tum­bles

Last year
Health Tech

Claris rais­es $57M in Se­ries A as it awaits key tri­al read­out on eye drug

Last year
Financing
Startups

4BIO pulls De­vel­op­ment Bank of Japan to dip its toes in­to UK life sci­ence by back­ing lat­est fund

Last year
Financing
Deals

Rhythm li­cens­es obe­si­ty drug for $100M; Gala­pa­gos teams up with Brid­Gene; In­sil­i­co’s new deal

Last year
News Briefing

Eli Lil­ly jumps in­to di­rect-to-con­sumer weight loss are­na

Last year
Pharma
Marketing

Ex­clu­sive: Roger Perl­mut­ter on the biggest prob­lem in Big Phar­ma, leav­ing Mer­ck, and build­ing Eikon

Last year
People
Startups
First page Previous page 222223224225226227228 Next page Last page
A service from the Financial Times